Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters

European Journal of Clinical Investigation

Volumn 41, Issue 9, 2011, Pages 921-928

  Tréguier, Morgan ^a   Briand, François ^b   Boubacar, Adamou ^a   André, Agnès ^a   Magot, Thierry ^a   Nguyen, Patrick ^c   Krempf, Michel ^a   Sulpice, Thierry ^b   Ouguerram, Khadija ^a  

^a INSERM   (France)

^b Prologue Biotech   (France)

^c LUNAM UNIVERSITÉ   (France)

Author keywords

Atherosclerosis; Dyslipidemia; Hamster; Macrophage; Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRITIUM; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BIOCHEMISTRY; CELL LABELING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DYSLIPIDEMIA; FECES; HAMSTER; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE CHOLESTEROL TRANSPORT;

ANIMALS; AORTA; BIOLOGICAL TRANSPORT; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CRICETINAE; DIET; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; LIVER; MACROPHAGES, PERITONEAL; MESOCRICETUS;

EID: 79961015558     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02478.x     Document Type: Article

References (29)

1. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975;1:16-9.
2. Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 2006;113:2548-55.
3. Schwartz CC, Vandenbroek JM, Cooper PS. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J Lipid Res 2004;45:1594-607.
4. Ouguerram K, Krempf M, Maugeais C, Maugére P, Darmaun D, Magot T. A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans. Metabolism 2002;51:5-11.
5. Chan DC, Barrett PH, Watts GF. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol 2006;17:28-36.
6. Ginsberg HN, Maccallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2009;4:113-9.
7. Degoma E, Degoma R, Rader DJ. Beyond High-Density Lipoprotein Cholesterol Levels. J Am Coll Cardiol 2008;51:2199-211.
8. Tanigawa H, Billheimer JT, Tohyama J et al. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 2007;116:1267-73.
9. Tchoua U, D'souza W, Mukhamedova N et al. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport. Cardiovasc Res 2008;1:77.
10. Briand F. The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport. Curr Opin Investig Drugs 2010;11:289-97.
11. Briand F, Tréguier M, André A et al. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. J Lipid Res 2010;51:763-70.
12. Li YM, Baviello G, Vlassara H et al. Glycation products in aged thioglycollate medium enhance the elicitation of peritoneal macrophages. J Immunol Methods 1997;28:201.
13. Delaney B, Nicolosi RJ, Wilson TA et al. Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J Nutr 2003;133:468-75.
14. Jiang XC, Moulin P, Quinet E et al. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem 1991;5:266.
15. Lewis GF, Murdoch S, Uffelman K et al. Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone. Diabetes 2004;53:2893-900.
16. Liu GL, Fan LM, Redinger RN. The association of hepatic apoprotein and lipid metabolism in hamsters and rats. Comp Biochem Physiol A Comp Physiol 1991;99:223-8.
17. Shimomura I, Bashmakov Y, Shimano H et al. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. Proc Natl Acad Sci 1997;11:94.
18. Zhang Z, Wang H, Jiao R et al. Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol Nutr Food Res 2009;53:921-30.
19. Basciano H, Miller AE, Naples M et al. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am J Physiol Endocrinol Metab 2009;297:E462-73.
20. Jia X, Ebine N, Demonty I et al. Hypocholesterolaemic effects of plant sterol analogues are independent of ABCG5 and ABCG8 transporter expressions in hamsters. Br J Nutr 2007;98:550-5.
21. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109:1125-31.
22. Tréguier M, Doucet C, Moreau M et al. Transcription factor sterol regulatory element binding protein 2 regulates scavenger receptor Cla-1 gene expression. Arterioscler Thromb Vasc Biol 2004;24:2358-64.
23. Woollett LA, Spady DK, Dietschy JM. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentration in hamsters. Differential effects of fatty acid chain length. J Clin Invest 1989;84:119-28.
24. Zhang Y, Da Silva JR, Reilly M et al. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005;115:2870-4.
25. Palmer AM, Murphy N, Graham A. Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo)A1 from human macrophage foam cells. Atherosclerosis 2004;173:27-38.
26. Horton JD, Cuthbert JA, Spady DK. Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J Biol Chem 1995;270:5381-7.
27. Bernard DW, Rodriguez A, Rothblat GH et al. cAMP stimulates Cholesteryl ester clearance to high density lipoproteins in J7774 macrophages. J Biol Chem 1991;266:710-6.
28. Mazzone T, Reardon C. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. J Lipid Res 1994;35:1345-53.
29. Linder MD, Mäyränpää MI, Peränen J et al. Rab8 regulates ABCA1 cell surface expression and facilitates cholesterol efflux in primary human macrophages. Arterioscler Thromb Vasc Biol 2009;29:883-8.